CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Cash flows from operating activities
Net increase (decrease) in net assets resulting from operations	$ (15,583)	$ (10,275)	$ (31,956)
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used for) operating activities:
Purchases of investments	(149,463)	(191,875)	(92,524)
Net change in short-term investments	(6,329)	(6)	10,735
Capitalized payment-in-kind interest	(1,421)	(6,677)	(6,074)
Proceeds from sales of investments	56,182	64,733	52,415
Proceeds from principal payments	56,816	70,262	59,578
Net realized (gain) loss on investments	126,046	9,639	10,977
Net change in unrealized (appreciation) depreciation on investments	(100,002)	12,921	29,356
Amortization of premium and accretion of discount, net	(1,352)	(3,958)	(4,999)
Net realized gain on repurchase of debt			(1,237)
Amortization of discount (premium) on long term debt	1,312	1,496	1,153
Increase (decrease) in operating assets and liabilities:
(Increase) decrease in interest receivable	(1,279)	612	(73)
(Increase) decrease in dividends receivable	100	(1,540)	14
(Increase) decrease in due from portfolio company	135	701	(220)
(Increase) decrease in due from affiliates	17	(17)	15
(Increase) decrease in prepaid expenses and other assets	(2,878)	(60)	(151)
Increase (decrease) in due to affiliates	(4,259)	(4,074)	786
Increase (decrease) in interest payable	13	(299)	(26)
Increase (decrease) in accrued expenses and other liabilities	190	(72)	(381)
Net cash provided by (used for) operating activities	(41,755)	(58,489)	27,388
Cash flows from financing activities
Purchase of debt			(4,067)
Issuance of notes payable		55,229
Borrowings under credit facility	10,000	10,000
Repayments under credit facility		(10,000)
Repayment of notes payable		(30,293)
Proceeds from issuance of common stock	37,507		31,748
Payments of deferred financing costs	(1,287)	(550)	(1,500)
Distributions paid	(13,023)	(9,934)	(4,993)
Net cash provided by (used for) financing activities	33,197	14,452	21,188
Net increase (decrease) in cash	(8,558)	(44,037)	48,576
Cash and cash equivalents and restricted cash, beginning of period	9,145	53,182	4,606
Cash and cash equivalents and restricted cash, end of period	587	9,145	53,182
Supplemental disclosure of non-cash financing activities:
Distributions declared, not yet paid			1,911
Common stock distributed	0	1,720	7,783
Common stock issued in-kind	2,600	13,239
Supplemental disclosure of cash flow information:
Cash paid for excise tax	162	27	233
Cash paid for interest	$ 9,355	$ 9,230	$ 7,996